KRRO Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

11.940

Open

11.515

VWAP

11.73

Vol

181.34K

Mkt Cap

108.11M

Low

11.490

Amount

2.13M

EV/EBITDA(TTM)

Total Shares

9.42M

21.41M

EV/OCF(TTM)

P/S(TTM)

Korro Bio, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The Company is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic medicines. Using its oligonucleotide-based approach, the Company brings its medicines to patients by leveraging its proprietary platform. The Company’s first development candidate, KRRO-110, is in development as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD) that has the potential to be disease-modifying and provide a differentiated therapeutic option.

Events Timeline

(ET)

2026-03-09

07:50:00

Korro Bio Enters Agreement for $85 Million Financing

2026-01-28 (ET)

2026-01-28

16:30:00

Fed Holds Rates Steady, Nasdaq Slightly Up

News

8.5

03-09Newsfilter

PinnedKorro Bio Secures $85 Million PIPE Financing to Advance RNA Editing Programs

8.5

03-09seekingalpha

Korro Bio Secures $85 Million in PIPE Financing

6.5

02-19Benzinga

Wall Street Analysts Adjust Ratings

6.0

01-29stocktwits

Korro Bio's KRRO-121 Receives Strong Analyst Upgrades

6.0

01-29Benzinga

Wall Street Analysts Adjust Ratings

6.5

01-29Benzinga

Wall Street Analysts Adjust META Stock Outlook

8 Analyst Rating

Wall Street analysts forecast KRRO stock price to rise

0 Buy

8 Hold

0 Sell

Hold

Current: 0.000

Low

7.00

Averages

25.75

High

81.00

Current: 0.000

Low

7.00

Averages

25.75

High

81.00

Clear Street

Hold

Buy

upgrade

$10 -> $18

AI Analysis

2026-02-18

Reason

Clear Street

Price Target

$10 -> $18

AI Analysis

2026-02-18

upgrade

Hold

Buy

Reason

Clear Street upgraded Korro Bio to Buy from Hold with a price target of $18, up from $10. The firm believes new lead program, KRRO-121 for hyperammonemia, clearly addresses an unmet need in the space and that the scientific rationale behind the approach is "strong," the analyst tells investors. While acknowledging that significant clinical de-risking remains, it believes the risk/reward proposition "skews strongly in favor" of Korro at current trading levels.

William Blair

analyst

Market Perform -> Outperform

upgrade

$48.53

2026-02-17

Reason

William Blair

analyst

Price Target

$48.53

2026-02-17

upgrade

Market Perform -> Outperform

Reason

William Blair upgraded Korro Bio to Outperform from Market Perform. The firm views the risk/reward as favorable for the OPERA Platform and KRRO-121, notes the analyst, who estimates a risk-adjusted net present value of $48.53 per share.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for KRRO

Unlock Now

Valuation Metrics

The current forward P/E ratio for Korro Bio Inc (KRRO.O) is -1.03, compared to its 5-year average forward P/E of -3.76. For a more detailed relative valuation and DCF analysis to assess Korro Bio Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-3.76

Current PE

-1.03

Overvalued PE

-1.89

Undervalued PE

-5.63

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

72.08

Current PS

40.98

Overvalued PS

227.81

Undervalued PS

-83.66

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

low float

Intellectia · 38 candidates

Market Cap: 100.00M - 2.50BPrice: $3.00 - $40.00List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 1,000,000Floating Shares: <= 8,000,000

Ticker

Name

Market Cap$

KZIA

Kazia Therapeutics Ltd

113.47M

IBTA

Ibotta Inc

624.58M

ARQQ

Arqit Quantum Inc

249.33M

BANX

ArrowMark Financial Corp

136.73M

VTVT

vTv Therapeutics Inc

136.54M

CFBK

CF Bankshares Inc

193.26M

add stocks available less then 1 mill

Intellectia · 36 candidates

Price: $1.00 - $20.00Volume: <= 1,000,000Price Change Pct: >= $8.00Shares Outstanding: <= 20,000,000

Ticker

Name

Market Cap$

GDEV

GDEV Inc

331.78M

AGCC

Agencia Comercial Spirits Ltd

320.05M

ONEW

OneWater Marine Inc

236.56M

USGO

US GoldMining Inc

188.48M

BHST

Bioharvest Sciences Inc

119.39M

CPSH

CPS Technologies Corp

106.26M

show all 38

Intellectia · 25 candidates

Market Cap: <= 500.00MPrice: <= $10.00Weekly Average Turnover: >= 1,000,000Moving Average Relationship: PriceCrossAboveMA5, PriceCrossAboveMA20Shares Outstanding: <= 25,000,000

Ticker

Name

Market Cap$

BOOM

DMC Global Inc

182.43M

RMAX

Re/Max Holdings Inc

163.26M

ANIK

Anika Therapeutics Inc

137.29M

NAMM

Namib Minerals

121.31M

LAKE

Lakeland Industries Inc

89.53M

KRRO

Korro Bio Inc

89.18M

Whales Holding KRRO

TCG Crossover Management, LLC

New Enterprise Associates, Inc.

Qiming Weichuang Venture Capital Management (Shanghai) Company Limited

Trading Trends

People Also Watch

Frequently Asked Questions

What is Korro Bio Inc (KRRO) stock price today?

The current price of KRRO is 11.76 USD — it has increased 2.44

What is Korro Bio Inc (KRRO)'s business?

What is the price predicton of KRRO Stock?

Wall Street analysts forecast KRRO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KRRO is25.75 USD with a low forecast of 7.00 USD and a high forecast of 81.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Korro Bio Inc (KRRO)'s revenue for the last quarter?

Korro Bio Inc revenue for the last quarter amounts to 1.09M USD, decreased

What is Korro Bio Inc (KRRO)'s earnings per share (EPS) for the last quarter?

Korro Bio Inc. EPS for the last quarter amounts to -1.92 USD, decreased -15.04

How many employees does Korro Bio Inc (KRRO). have?

Korro Bio Inc (KRRO) has 104 emplpoyees as of March 11 2026.

What is Korro Bio Inc (KRRO) market cap?

Today KRRO has the market capitalization of 108.11M USD.

KRRO Overview

KRRO Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding KRRO

Trading Trends

People Also Watch

Frequently Asked Questions

What is Korro Bio Inc (KRRO) stock price today?

What is Korro Bio Inc (KRRO)'s business?

What is the price predicton of KRRO Stock?

What is Korro Bio Inc (KRRO)'s revenue for the last quarter?

What is Korro Bio Inc (KRRO)'s earnings per share (EPS) for the last quarter?

How many employees does Korro Bio Inc (KRRO). have?

What is Korro Bio Inc (KRRO) market cap?